{"id":"W4200437485","doi":"10.3390/ph14121270","title":"Expanding the Use of PARP Inhibitors as Monotherapy and in Combination in Triple-Negative Breast Cancer","year":2021,"lang":"en","type":"review","venue":"Pharmaceuticals","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Breast cancer; Triple-negative breast cancer; BRCA mutation; PARP inhibitor; Metastatic breast cancer; Oncology; Chemotherapy; Internal medicine; Cancer; Cancer research; Poly ADP ribose polymerase; Polymerase; Biology; Gene; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000653624,0.000683865,0.001279278,0.001790204,0.0001720235,0.000763185,0.0008003798,0.0008423273,0.003988042],"category_scores_gemma":[0.0006732419,0.0002608882,0.0007890869,0.001291828,0.0002758847,0.0009877919,0.0005481889,0.001812021,0.001461907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004841395,"about_ca_system_score_gemma":0.0006370744,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009605812,"about_ca_topic_score_gemma":0.00209453,"domain_scores_codex":[0.9997963,0.00005151695,0.00002765673,0.00003153303,0.0000724803,0.00002054876],"domain_scores_gemma":[0.9997711,0.0001170666,0.00003789112,0.000006223008,0.00005269,0.00001504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001676088,0.00009079066,0.00009229976,0.02028982,0.0001718962,0.0001223166,0.00004611308,0.0004160189,0.001316466,0.00228188,0.01710981,0.957895],"study_design_scores_gemma":[0.0001161525,0.0003390793,0.001115154,0.008364945,0.0003235341,0.001175194,0.00005710215,0.0002272594,0.0007043772,0.001705877,0.9858506,0.00002068008],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001736762,0.9986009,0.00007469956,0.0001403193,0.00008635083,0.000006161145,0.00001522106,0.000005494383,0.0008970875],"genre_scores_gemma":[0.0009257894,0.9982111,0.0001274222,0.0001928813,0.00006310575,0.000008413104,0.00002648578,0.000001463525,0.0004433074],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003988042,"threshold_uncertainty_score":0.01334137,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2316399911823588,"score_gpt":0.492579449085121,"score_spread":0.2609394579027622,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}